These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1677293)

  • 1. [Changes in the guanylate cyclase activity of human thrombocytes during ADP-inducible aggregation].
    Chirkov IuIu; Belushkina NN; Tyshchuk IA; Severina IS
    Biull Eksp Biol Med; 1991 Feb; 111(2):152-4. PubMed ID: 1677293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of guanyl cyclase in the regulation of aggregation of human thrombocytes].
    Chirkov IuIu; Belushkina NN; Tyshchuk IA; Severina IS
    Vestn Akad Med Nauk SSSR; 1991; (10):51-4. PubMed ID: 1686950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in reactivity of human platelet guanylate cyclase during aggregation potentiates the disaggregating capacity of sodium nitroprusside.
    Chirkov YY; Belushkina NN; Tyshchuk IA; Severina IS; Horowitz JD
    Clin Exp Pharmacol Physiol; 1991 Jul; 18(7):517-24. PubMed ID: 1680588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in activating ability of human platelet guanylate cyclase during aggregation.
    Severina IS; Belushkina NN
    Biochem Int; 1992 Dec; 28(4):621-31. PubMed ID: 1362351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Soluble platelet guanylate cyclase: significance of heme in regulating enzymatic activity and the role of the enzyme in platelet aggregation].
    Severina IS
    Biokhimiia; 1994 Mar; 59(3):325-39. PubMed ID: 7910045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble guanylate cyclase of platelets: function and regulation in normal and pathological states.
    Severina IS
    Adv Enzyme Regul; 1992; 32():35-56. PubMed ID: 1353937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].
    Karrenbrock B; Grewe R; Loeschke K; Gerzer R
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):251-4. PubMed ID: 2882462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
    Severina IS; Belushkina NN; Grigoryev NB
    Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanidine thiol--a new activator of soluble guanylate cyclase with antihypertensive and antiaggregatory properties.
    Severina IS; Bussygina OG; Belushkina NN; Grigoryev NB
    Biochem Mol Biol Int; 1995 Jul; 36(4):913-25. PubMed ID: 8528155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
    Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ
    Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation.
    Bussygina OG; Pyatakova NV; Khropov YV; Ovchinnikov IV; Makhova NN; Severina IS
    Biochemistry (Mosc); 2000 Apr; 65(4):457-62. PubMed ID: 10810184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guanylate cyclase from human blood platelets].
    Chirkov IuIu; Tyshchuk IA; Belushkina NN; Severina IS
    Biokhimiia; 1987 Jun; 52(6):956-63. PubMed ID: 2889477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase.
    Brüne B; Ullrich V
    Mol Pharmacol; 1987 Oct; 32(4):497-504. PubMed ID: 2890093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mepacrine-induced elevation of cyclic GMP levels and acceleration of reversal of ADP-induced aggregation in washed rabbit platelets.
    Matsuoka I; Suzuki T
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):341-53. PubMed ID: 6147364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of nitric oxide-sensitive guanylyl cyclase in human platelets before and after aggregation.
    Kempfert J; Behrends S
    Platelets; 2003; 14(7-8):429-35. PubMed ID: 14713512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble guanylyl cyclase is the only enzyme responsible for cyclic guanosine monophosphate synthesis in human platelets.
    Gambaryan S; Subramanian H; Rukoyatkina N; Herterich S; Walter U
    Thromb Haemost; 2013 May; 109(5):973-5. PubMed ID: 23467662
    [No Abstract]   [Full Text] [Related]  

  • 19. [A new activator of soluble guanylate cyclase generated by nitric oxide and having antihypertensive and anti-aggregation properties].
    Busygina OG; Belushkina NN; Grigor'ev NB; Severina IS
    Biokhimiia; 1995 Sep; 60(9):1460-7. PubMed ID: 8562654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conditions of activation of guanylate cyclase from human platelets].
    Chirkov IuIu; Tyshchuk IA; Severina IS
    Biokhimiia; 1988 Sep; 53(9):1520-6. PubMed ID: 2904828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.